Estimating costs for economic evaluation

ABC: Adjuvant Breast Cancer trial

 

AFORRD: Atorvastatin and fish oil in diabetes

 

Alzheimer's disease progression: health and social care costs

 

ART: Arterial Revascularisation Trial

 

B-AHEAD Breast - Activity and Healthy Eating after Diagnosis.

Feasibility study to compare three weight control programmes during adjuvant treatment for early breast cancer

COMET: COst Models for Evaluating Technologies

 

CRISP

Coronary artery grafting in high risk patients. A randomised trial of off-pump versus on-pump surgery (the CRISP Trial)

Development of a DNA array-based chip for inflammatory bowel disease (completed)

 

Development of a multi-modality blood conservation strategy in cardiothoracic surgery

 

FOXFIRE: First line treatment of patients with liver metastatic colorectal cancer

An open-label randomised phase III trial of 5-fluorocil, OXaliplatin and Folinic acid +/- Interventional Radio-Embolisation as first line treatment for patients with unresectable liver-only or liver-predominant metastatic colorectal cancer.

Genetic testing of somatic mutations in common cancers (completed)

 

Home Visiting Trial and Follow-up

 

ISAT: International Subarachnoid Aneurysm Trial

Economic evaluation alongside ISAT: a trial of endovascular therapy versus neurosurgical therapy in aneurysmal subarachnoid haemorrhage

IVAN

A randomised controlled trial of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation

KAT: The Knee Arthroplasty Trial

 

MACH trial

Treatment of Child Anxiety Disorder in the context of Maternal Anxiety: a randomised controlled trial

MCADD

Cost-effectiveness analysis of newborn screening for medium chain acyl CoA dehydrogenase (MCAD) deficiency to inform screening policy: a national collaborative study

Novel genomic technologies in the NHS (completed)

 

OT / PT for people with stroke

Economic evaluation of a targeted occupational therapy and physiotherapy intervention for people with stroke living in nursing and residential homes in Oxfordshire

PDMED: Parkinson's Disease Medicines trial

A large randomised assessment of the relative cost-effectiveness of classes of drugs for Parkinson's disease.